Pyrimidine compound and pharmaceutically acceptable salts thereof
US5358945A · kind A · utility
11Cited by
0References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 30, 1992 |
| Grant date | Oct 25, 1994 |
| Priority date | — |
| Expiry date | Mar 30, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to pyrimidine compounds represented by the formula ##STR1## (wherein X is a substituted or a cyclic amino group and Y is a substituted amino group or a substituted carbonyl group) or their pharmaceutically acceptable salts, and a therapeutic agent for neurological diseases comprising the compounds. These compounds are useful for treatment of various disorders in nervous systems since they are effective on growth of neurons and promotion of the formation and elongation of neutrites.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.